Procedural Efficiency, Efficacy, and Safety of High-Power, Short-Duration Radiofrequency Ablation Delivered by STSF Catheter for Paroxysmal Atrial Fibrillation
Table 2
Baseline demographic and patient characteristics.
Characteristics
Control group (n = 36)
Study group (n = 36)
value
Sex (male/female)
20/16
27/9
0.083
Age (years)
63.11 ± 9.96
58.92 ± 11.92
0.110
BMI (kg/m2)
25.38 ± 3.24
24.11 ± 2.98
0.089
Hypertension (n (%))
18 (50.0)
20 (55.6)
0.637
Diabetes (n (%))
7 (19.4)
6 (16.7)
0.759
Coronary heart disease (n (%))
11 (30.6)
6 (16.7)
0.165
Heart failure (n (%))
3 (8.3)
1 (2.8)
0.303
Stroke/TIA (n (%))
4 (11.1)
2 (5.6)
0.394
Mean AF duration (months)
28.31 ± 31.46
35.50 ± 36.38
0.716
CHA2DS2-VASC
2.31 ± 1.95
1.69 ± 1.49
0.191
HAS-BLED
0.64 ± 0.59
0.44 ± 0.61
0.130
eGFR (ml/min/1.73 m2)
89.48 ± 20.71
91.66 ± 26.94
0.165
LA diameter (mm)
38.08 ± 6.40
38.19 ± 6.46
0.942
LV diameter (mm)
45.31 ± 5.06
47.31 ± 4.62
0.084
LV EF (%)
61.53 ± 4.07
63.04 ± 4.40
0.136
Data are expressed as mean ± SD or n (%). BMI, body mass index; TIA, transient ischemic attack; AF, atrial fibrillation; eGFR, estimated glomerular filtration rate; LV, left ventricular; EF, ejection fraction.
